Amarin Corp Plcuk (AMRN) EBITDA Margin (QoQ) (2013 - 2026)
Amarin Corp Plcuk (AMRN) EBITDA Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -334.00 |
| Mar 31, 2026 | -1,226.00 |
| Dec 31, 2025 | 950.00 |
| Sep 30, 2025 | -38.00 |
| Jun 30, 2025 | 1,790.00 |
| Mar 31, 2025 | 4,442.00 |
| Dec 31, 2024 | -2,480.00 |
| Sep 30, 2024 | -5,873.00 |
| Jun 30, 2024 | 2,326.00 |
| Mar 31, 2024 | -1,756.00 |
| Dec 31, 2023 | 2,600.00 |
| Sep 30, 2023 | -259.00 |
| Jun 30, 2023 | -972.00 |
| Mar 31, 2023 | -955.00 |
| Dec 31, 2022 | -490.00 |
| Sep 30, 2022 | 6,081.00 |
| Jun 30, 2022 | -3,662.00 |
| Mar 31, 2022 | -4,108.00 |
| Dec 31, 2021 | 2,037.00 |
| Sep 30, 2021 | -1,488.00 |